title: Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab.
authors.affiliation: Oncology Department, Bon Secours Hospital, Metz, France. c.platini@chr-metz-thionville.fr
authors.forename: Christian
authors.initials: C
authors.lastname: Platini
authors.forename: Jérome
authors.initials: J
authors.lastname: Long
authors.forename: Sabine
authors.initials: S
authors.lastname: Walter
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001932:Brain Neoplasms / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000556:secondary; D001943:Breast Neoplasms / Q000378:metabolism / Q000628:therapy*; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D008577:Meningeal Neoplasms / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000556:secondary; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab